Ming-Jui, H, Hu, P, Ming-Yow, H. Coronary artery spasm: review and update. Int J Med Sci
2014; 11: 1161–1171.
Miwa, K, Nakagawa, K, Yoshida, N, et al. Lipoprotein (a) is a risk factor for occurrence of acute myocardial infarction in patients with coronary vasospasm. J Am Coll Cardiol
2000; 35: 1200–1205.
Jasmin, R, Ng, C-T, Sockalingam, S, et al. Myocardial infarction with normal coronaries: an unexpected finding in a 13-year-old girl with systemic lupus erythematosus. Lupus
2013; 22: 1518–1522.
Subramanian, S, Gaum, WE. Acute myocardial infarction caused by transient coronary vasospasm in a child with Kawasaki disease and no coronary aneurysms. Pediatr Cardiol
2010; 31: 875–877.
Lee, J, Seok, J, Kim, Y, et al. Atropine injection followed by coronary artery spasm with ventricular tachycardia during spinal anesthesia. Korean J Anesthesiol
2013; 65: 66–70.
Kounis, NG. Kounis syndrome: an update on epidemiology, pathogenesis, diagnosis and therapeutic management. Clin Chem Lab Med
2016; 54: 1545–1559.
Biteker, M, Duran, NE, Biteker, F, et al. Kounis syndrome: first series in Turkish patients. Anadolu Kardiyol Derg
2009; 9: 59–60.
Ebo, DG, Leysen, J, Mayorga, C, et al. The in vitro diagnosis of drug allergy: status and perspectives. Allergy
2011; 66: 1275–1286.
Demoly, P, Adkinson, NF, Brockow, K, et al. International consensus on drug allergy. Allergy
2014; 69: 420–437.
Brockow, K, Garvey, LH, Aberer, W, et al. Skin test concentrations for systemically administered drugs – an ENDA/EAACI Drug Allergy Interest Group position paper. Allergy
2013; 68: 702–712.